| Recruiting | A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema NCT06962839 | Boehringer Ingelheim | Phase 2 |
| Recruiting | Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edema NCT06825702 | Kiora Pharmaceuticals, Inc. | Phase 2 |
| Enrolling By Invitation | Implementation of the Intravitreal Injection Administered by Nurses NCT06511700 | Corporacion Parc Tauli | — |
| Active Not Recruiting | Incidence of Macular Edema in a Uveitis Population NCT06686641 | Aalborg University Hospital | — |
| Recruiting | A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema NCT06305416 | Incepta Pharmaceuticals Ltd | Phase 3 |
| Unknown | Evaluation of Macular Edema After AcF Implant's Injection, 1 Month After the Last DXM Implant NCT05996822 | Nantes University Hospital | — |
| Completed | A Study to Evaluate the Usability of the SB11 PFS in Subjects With Wet AMD or Macular Oedema Secondary to RVO NCT06176963 | Samsung Bioepis Co., Ltd. | Phase 2 |
| Unknown | Ultra-wide-field Fluorescein Angiography in Patients With Macular Edema Secondary to Retinal Vein Occlusion NCT04140448 | Renmin Hospital of Wuhan University | — |
| Recruiting | Micropulsed Laser in Patients With Macular Oedema in Retinal Dystrophies NCT05976139 | Fondazione G.B. Bietti, IRCCS | N/A |
| Completed | Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DM NCT06011798 | Unity Biotechnology, Inc. | Phase 2 |
| Completed | The Role of Radial Peripapillary Vessel Density in Irvine-gass Syndrome NCT06436170 | Federico II University | — |
| Active Not Recruiting | Effect of AIV007 by Periocular Administration in Subjects with Macular Edema Secondary to Neovascular Age-rela NCT05698329 | AiViva BioPharma, Inc. | Phase 1 |
| Unknown | Comparison of Combined Intravitreal Bevacizumab and Oral Acetazolamide Versus Intravitreal Bevacizumab Alone f NCT05290948 | Shahid Beheshti University of Medical Sciences | Phase 2 |
| Unknown | Changes After Suprachoroidal Injection. NCT05288192 | Benha University | N/A |
| Unknown | Macular Thickness and Visual Acuity in Diabetic Hypertensive Patients NCT05209971 | Sohag University | — |
| Unknown | High Resolution Optical Coherence Tomography NCT05130385 | Insel Gruppe AG, University Hospital Bern | — |
| Completed | Fundus Image-guided Focal Electroretinography, Usability Study NCT05100511 | Maculaser Oy | N/A |
| Terminated | Effectiveness of Periocular Drug Injection in CATaract Surgery NCT05158699 | Luigi Rondas | Phase 3 |
| Completed | A Study to Evaluate an Updated Dexamethasone Intravitreal (Into the Eye) Applicator in Adult Participants With NCT04976777 | AbbVie | Phase 3 |
| Recruiting | Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin NCT06595355 | Isfahan University of Medical Sciences | Phase 2 / Phase 3 |
| Completed | Functional and Anatomical Outcomes of Dexamethasone Intra-vitreal Implant in Patients with Resistant Macular E NCT05003258 | Assiut University | N/A |
| Completed | Comparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Ov NCT07090044 | Retina Research Institute, LLC | Phase 4 |
| Completed | Impact of the Navilas ® Micropulse Laser Treatment for Macular Edema Within the CHU Brugmann Hospital Macular NCT04857099 | Brugmann University Hospital | — |
| Completed | A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Centr NCT04740931 | Hoffmann-La Roche | Phase 3 |
| Completed | A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branc NCT04740905 | Hoffmann-La Roche | Phase 3 |
| Unknown | BEOVU Versus Eylea in the Treatment of Diabetic Macular Edema NCT04955171 | Benha University | Phase 3 |
| Unknown | Smart-TV Application for the Self Examination of the Distance Visual Acuity in Macular Edema Patients NCT04739137 | Democritus University of Thrace | — |
| Completed | A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients NCT04635800 | Novartis Pharmaceuticals | Phase 1 |
| Unknown | Effects of Adding Triamcinolone Acetonide to Conbercept Treatment for Refractory Diabetic Macular Edema (CONTE NCT04627402 | Zhongshan Ophthalmic Center, Sun Yat-sen University | N/A |
| Completed | Evaluation of the Retinal Health Monitoring System Thickness Module NCT04499703 | Kubota Vision Inc. | — |
| Unknown | Diabetic Macular Edema (DME) Treatment With Ranibizumab and Dexamethasone or Ranibizumab Only. NCT04601675 | He Eye Hospital | N/A |
| Completed | A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With M NCT04592419 | Kodiak Sciences Inc | Phase 3 |
| Terminated | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Particip NCT04292912 | GlaxoSmithKline | Phase 1 |
| Recruiting | MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema NCT04187443 | Shenzhen MingSight Relin Pharmaceuticals Co., Ltd. | Phase 1 |
| Withdrawn | Study Evaluating Retinal Health Monitoring System Thickness Module NCT04428242 | Kubota Vision Inc. | — |
| Terminated | Effects of Conbercept in Refractory Uveitic Macular Edema and VEGF NCT04296838 | Peking Union Medical College Hospital | Phase 2 / Phase 3 |
| Unknown | Bimodal and Coaxial High Resolution Ophtalmic Imaging NCT04620876 | Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts | N/A |
| Unknown | Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole NCT04120311 | Targeted Therapy Technologies, LLC | Phase 1 |
| Completed | Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China NCT03908307 | Allergan | Phase 4 |
| Completed | The Use of Suprachoroidal Triamcinolone Acetonide to Treat Macular Edema in Retinal Vein Occlusion NCT05038072 | Damascus University | N/A |
| Recruiting | High Resolution, High-speed Multimodal Ophthalmic Imaging NCT04129021 | Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts | N/A |
| Completed | Long Term Safety of Cooling Anesthesia for Intravitreal Injection NCT03956797 | Recens Medical, Inc. | N/A |
| Completed | Study Assessing AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) NCT03739593 | Aerie Pharmaceuticals | Phase 2 |
| Completed | Targeted Laser in Diabetic Macular Edema NCT03751501 | Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts | N/A |
| Terminated | Macular Edema Nepafenac vs. Difluprednate Uveitis Trial NCT01939691 | University of California, San Francisco | Phase 4 |
| Completed | ILM Peeling in PDR Patients Undergoing PPV for VH NCT03660371 | Rush Eye Associates | N/A |
| Completed | PPV With Internal Limiting Membrane Peeling for Treatment-Naïve DME NCT03660345 | Rush Eye Associates | Phase 3 |
| Withdrawn | Effect of Vitrectomy on the Evolution of Refractory Diabetic Macular Edema NCT03603990 | Fondation Ophtalmologique Adolphe de Rothschild | N/A |
| Unknown | Influence of Systemic Parameters in Diabetic Macular Edema - LIPSIA Study NCT03762226 | University of Leipzig | — |
| Completed | Navigated Laser In Branch Retinal Vein Occlusion Study NCT03651011 | Odense University Hospital | N/A |
| Completed | A Study to Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME) NCT03499223 | Oxurion | Phase 2 |
| Terminated | Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Followin NCT03203447 | Clearside Biomedical, Inc. | Phase 3 |
| Unknown | High Resolution Retina Imaging NCT04128150 | Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts | — |
| Completed | A Study to Evaluate the Effectiveness of Intravitreal Aflibercept in Patients With Diabetic Macular Edema and/ NCT03161912 | Bayer | — |
| Completed | Risk Factors for the Recurrent Postoperative Macular Edema Treated With OZURDEX NCT05372562 | Peking University | — |
| Completed | Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial NCT02623426 | JHSPH Center for Clinical Trials | Phase 3 |
| Unknown | Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab NCT03056092 | Unity Health Toronto | Phase 4 |
| Unknown | Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept NCT03056079 | Unity Health Toronto | Phase 4 |
| Terminated | Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Follow NCT02980874 | Clearside Biomedical, Inc. | Phase 3 |
| Completed | A Study to Evaluate the Safety and Efficacy of THR-317 for the Treatment of Diabetic Macular Oedema (DME) NCT03071068 | ThromboGenics | Phase 2 |
| Completed | Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME) NCT02818998 | Bayer | Phase 3 |
| Completed | Retrospective Study of the Safety and Efficacy of Patients With RVO in Subjects Who Completed Parent Study CLS NCT02956330 | Clearside Biomedical, Inc. | — |
| Completed | A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA6 NCT02867735 | Novartis Pharmaceuticals | Phase 1 |
| Completed | Analyzing Retinal Microanatomy in ROP NCT02887157 | Duke University | — |
| Completed | A Study to Assess the Effectiveness of Aflibercept in Routine Clinical Practice in Patients With Diabetic Macu NCT02850263 | Bayer | — |
| Completed | Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion NCT03223714 | Chengdu Kanghong Biotech Co., Ltd. | Phase 3 |
| Completed | Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular Edema NCT02732951 | Boehringer Ingelheim | Phase 2 |
| Completed | Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion NCT03108352 | Chengdu Kanghong Biotech Co., Ltd. | Phase 3 |
| Completed | A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Ve NCT02698566 | Genentech, Inc. | Phase 3 |
| Terminated | Epiretinal Membrane and Pseudophakic Cystoid Macular Edema NCT02693353 | Loma Linda University | — |
| Terminated | Intravitreal Dexamethasone Implant for Persistent Macular Thickening and Edema After Vitrectomy for Epiretinal NCT02995746 | Wills Eye | N/A |
| Terminated | Micropulsed Laser in Association With Anti-VEGF for the Treatment of Macular Edema in Diabetic Patients (LAMED NCT02650050 | Fondation Ophtalmologique Adolphe de Rothschild | N/A |
| Completed | A Safety and Efficacy Study of Dexamethasone Versus Laser Photocoagulation in Participants With Diabetic Macul NCT02121262 | Allergan | Phase 3 |
| Completed | Ranibizumab Plus Indomethacin NCT03261635 | Università degli Studi di Brescia | Phase 4 |
| Completed | Treatment of CNV With Aflibercept Combined With Pranoprofen Eye Drops or Nutraceutical Support With Omega-3 NCT03355638 | Università degli Studi di Brescia | Phase 4 |
| Completed | Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According t NCT02581995 | Bayer | Phase 4 |
| Completed | Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevaci NCT02559180 | Rishi Singh | Phase 4 |
| Completed | Simultaneous Therapy With Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edem NCT02623673 | Retina Clinic, Sao Paulo, Brazil | — |
| Terminated | Open-label, Multli-center, Phase 1b/2a Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontopho NCT02485249 | Eyegate Pharmaceuticals, Inc. | Phase 1 / Phase 2 |
| Completed | PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial NCT02374060 | JHSPH Center for Clinical Trials | Phase 3 |
| Unknown | Intravitreal Aflibercept Injection for Symptomatic Macular Edema From Retinal Artery Macroaneurysms NCT02403128 | Kamal Kishore, MD | Phase 1 |
| Completed | Study to Evaluate Home Vision Testing in Participants Who Receive Ranibizumab (Lucentis®) NCT02420132 | Hoffmann-La Roche | — |
| Unknown | Effect of Dexamethasone Implant in Hard Exudate Complicated With Diabetic Macular Edema NCT02399657 | Inje University | Phase 4 |
| Completed | Special Drug Use Investigation of EYLEA for Diabetic Macular Edema NCT02425501 | Bayer | — |
| Terminated | Pro-permeability and Pro-fibrosis Factors in the Aqueous of Patients With Retinal Diseases NCT02688309 | Johns Hopkins University | — |
| Completed | Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Follow NCT02303184 | Clearside Biomedical, Inc. | Phase 2 |
| Unknown | Spectral-domain Optical Coherence Tomography of the Eye NCT02614625 | Augenabteilung Allgemeines Krankenhaus Linz | — |
| Completed | Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uv NCT02255032 | Clearside Biomedical, Inc. | Phase 2 |
| Completed | An Observational Study of OZURDEX® in Diabetic Macular Edema (DME) NCT02188173 | Allergan | — |
| Completed | Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX® NCT02181530 | Allergan | — |
| Completed | A Study of Abicipar Pegol in Patients With Diabetic Macular Edema NCT02186119 | Allergan | Phase 2 |
| Terminated | Efficacy and Safety of Lucentis® Use in Patients With Diabetic Macular Edema Evaluating a Spaced Out Follow-up NCT02032173 | Novartis Pharmaceuticals | Phase 3 |
| Terminated | Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma NCT01471054 | Arman Mashayekhi | Phase 2 |
| Completed | Contrast Sensitivity and Diabetic Macular Edema NCT02217306 | Hospital Juarez de Mexico | — |
| Unknown | Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occ NCT02169648 | Tokyo Medical University | N/A |
| Unknown | Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation NCT03211741 | University Hospital, Ghent | Phase 4 |
| Completed | An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Oc NCT01908816 | Novartis Pharmaceuticals | Phase 3 |
| Terminated | Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF NCT01946399 | Retina Research Institute, LLC | N/A |
| Completed | A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion NCT01918371 | Allergan | — |
| Completed | A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion NCT01903720 | Allergan | Phase 4 |
| Completed | Ocular Manifestations in Rheumatic Diseases NCT03753893 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | — |
| Completed | TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema NCT01870440 | Northern California Retina Vitreous Associates | Phase 4 |
| Unknown | Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein Occlusion NCT01827722 | Valley Retina Institute | Phase 4 |
| Completed | Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With a NCT01771081 | Bayer | — |
| Completed | Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion NCT02614937 | Ohr Pharmaceutical Inc. | Phase 1 / Phase 2 |
| Completed | Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement NCT01783886 | Bayer | Phase 3 |
| Terminated | Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision NCT01795209 | Seoul National University Bundang Hospital | Phase 4 |
| Completed | Intravitreal Aflibercept Injection for Radiation Retinopathy NCT01579760 | Washington University School of Medicine | Phase 1 |
| Completed | A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients Wit NCT01673191 | Retinal Consultants of Arizona | Phase 2 |
| Completed | Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinop NCT01694212 | Eye Clinic Medic Zuljan Jukic | N/A |
| Unknown | A Pilot Study of the Effectiveness of Intra-operative Ozurdex® in Vitrectomy Surgery for Epiretinal Membranes NCT01701518 | Sunnybrook Health Sciences Centre | N/A |
| Completed | Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO NCT01692938 | Optos, PLC | — |
| Completed | Safety and Efficacy Study of Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal V NCT01660802 | Allergan | Phase 3 |
| Completed | A Retrospective Chart Review of OZURDEX® in Patients With Macular Edema NCT01805323 | Allergan | — |
| Completed | A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlu NCT01571557 | Allergan | — |
| Completed | Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema NCT01492400 | Allergan | Phase 2 |
| Completed | A Long-Term Safety Study of OZURDEX® in Clinical Practice NCT01539577 | Allergan | — |
| Completed | Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Centr NCT01535261 | Novartis Pharmaceuticals | Phase 3 |
| Completed | Japanese Safety Study of VEGF Trap-Eye in DME (Diabetic Macular Edema) NCT01512966 | Bayer | Phase 3 |
| Completed | Dexamethasone-Implant for the Treatment of Macula Edema Due to Irvine Gass Syndrome NCT01945892 | Ludwig-Maximilians - University of Munich | — |
| Completed | Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema NCT01476449 | Retina Vitreous Associates of Florida | Phase 2 |
| Completed | Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion NCT01618266 | Allergan | — |
| Completed | Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab NCT01471691 | Hanscom, Thomas, M.D. | Phase 1 / Phase 2 |
| Recruiting | Mechanical Properties of the Internal Limiting Membrane and Intraoperative Utility of Brilliant Blue g (Bbg) a NCT01485575 | University Hospital, Basel, Switzerland | — |
| Unknown | Autologous Plasmin and Fibrinolytic System in Diabetic Retinopathy NCT01478516 | Hallym University Medical Center | N/A |
| Completed | Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion NCT01427751 | Allergan | Phase 4 |
| Completed | A Retrospective Data Collection Study in Patients Receiving Dexamethasone Intravitreal Implant (Ozurdex®) for NCT01445626 | Allergan | — |
| Completed | Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusi NCT01568021 | Allergan | — |
| Completed | Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injection NCT01449682 | Retina Macula Institute | Phase 3 |
| Completed | Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion NCT01428388 | Barnes Retina Institute | N/A |
| Terminated | Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane NCT01410201 | Barnes Retina Institute | N/A |
| Completed | Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patien NCT01396083 | Novartis Pharmaceuticals | Phase 3 |
| Completed | DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO) NCT01662518 | Centro de Pesquisa Rubens Siqueira | Phase 1 / Phase 2 |
| Completed | Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO) NCT01411696 | Allergan | — |
| Completed | Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patien NCT01396057 | Novartis Pharmaceuticals | Phase 3 |
| Completed | Intravitreal Aflibercept Injection in Vision Impairment Due to DME NCT01331681 | Bayer | Phase 3 |
| Completed | A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Mac NCT01277302 | Genentech, Inc. | Phase 4 |
| Completed | A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patie NCT01315275 | Novartis Pharmaceuticals | Phase 4 |
| Completed | Use of Diagnostic Dye to Identify Areas of Leakeage,in the Retina, Prior to Receiving Focal Laser Treatment NCT01792141 | Retina Institute of Hawaii | — |
| Completed | REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study NCT01247220 | Retina Associates of Florida, P.A. | Phase 2 |
| Withdrawn | Autofluorescence in Uveitic and Diabetic Macular Edema NCT00956124 | St. Franziskus Hospital | — |
| Completed | Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macul NCT01298076 | University of Sydney | Phase 2 |
| Completed | Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema NCT01231633 | Long Island Vitreoretinal Consultants | N/A |
| Completed | Triple Therapy of Pars Plana Vitrectomy and Grid/Focal Laser for Diabetic Macular Edema (DME) NCT01202461 | Samsung Medical Center | Phase 1 |
| Completed | Ozurdex for Macular Edema Post Membrane Peeling NCT01273727 | Retina Specialists, PC | Phase 2 / Phase 3 |
| Terminated | Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina NCT02088151 | Insel Gruppe AG, University Hospital Bern | N/A |
| Completed | A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects NCT01100307 | Pfizer | Phase 3 |
| Unknown | Bevacizumab Versus Ranibizumab for the Treatment of Diabetic Macular Edema NCT01487629 | University of Sao Paulo | Phase 2 |
| Completed | Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO NCT01027650 | Allergan | Phase 1 / Phase 2 |
| Completed | Prophylactic Ketorolac Post Epiretinal Membrane Surgery NCT00974753 | Queen's University | N/A |
| Completed | Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract Surgery NCT01395069 | Queen's University | Phase 4 |
| Completed | Analysis of the Effect of Intravitreal Dexamethasone Injection on Diabetic Macular Edema After Cataract Surger NCT01030601 | University Health Network, Toronto | Phase 2 |
| Withdrawn | Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids NCT00846625 | University of Utah | Phase 2 |
| Terminated | Study to Assess the Safety and Tolerability of a Single Administration of FOV2302 (Ecallantide) in Patients Wi NCT00969293 | Fovea Pharmaceuticals SA | Phase 1 |
| Terminated | Efficacy Study of Methotrexate to Treat Sarcoid-associated Uveitis NCT00918554 | Assistance Publique - Hôpitaux de Paris | Phase 4 |
| Completed | Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to NCT00970957 | Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA | Phase 3 |
| Unknown | To Compare Visual Field Impairment in Conventional Double Frequency Nd: YAG Panretinal Photocoagulation With P NCT01023113 | L.V. Prasad Eye Institute | N/A |
| Unknown | Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occ NCT01123564 | University of Pecs | Phase 2 |
| Unknown | Comparison of Intravitreal Ranibizumab and Macular Grid-pattern Laser for Treatment of Diabetic Macular Edema NCT00994799 | Szeged University | — |
| Completed | Topic Ketorolac Added to Panphotocoagulation in Proliferative Diabetic Retinopathy NCT00907114 | Hospital Juarez de Mexico | Phase 2 |
| Terminated | Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina NCT00770770 | Alimera Sciences | Phase 2 |
| Completed | Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO) NCT00942864 | Novartis Korea Ltd. | Phase 3 |
| Withdrawn | Avastin for Post-photocoagulation Macular Edema NCT00801866 | Asociación para Evitar la Ceguera en México | Phase 4 |
| Completed | Function and Structure Imaging in Different Retinal Diseases: Retinal Leakage Analyzer Versus Optical Coherenc NCT00797524 | Association for Innovation and Biomedical Research on Light and Image | — |
| Completed | Microperimetry in Macular Edema NCT00791726 | St. Franziskus Hospital | — |
| Completed | A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retino NCT00782717 | Alcon Research | Phase 2 |
| Completed | Angiographie and OCT in Macula and Retinal Diseases NCT01603823 | Medical University of Vienna | — |
| Terminated | Effect of Topical Nepafenac in Macular Thickening Related to Pan-retinal Photocoagulation NCT00801905 | Asociación para Evitar la Ceguera en México | Phase 2 |
| Completed | An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Ve NCT01442064 | Genentech, Inc. | N/A |
| Terminated | Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal Photocoagulation NCT00804206 | Asociación para Evitar la Ceguera en México | Phase 4 |
| Terminated | A Study of MK0140 in Diabetic Patients With Macular Edema (0140-001) NCT00692614 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema NCT00900887 | Hospital Juarez de Mexico | Phase 2 |
| Completed | Major and Macular Branched Retinal Venous Occlusion NCT01219205 | Hallym University Medical Center | N/A |
| Completed | Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES) NCT00562406 | Klinikum Ludwigshafen | N/A |
| Completed | Morphological and Functional Retinal Changes Following Retinal Photocoagulation NCT00682240 | Medical University of Vienna | Phase 4 |
| Completed | A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch NCT00486018 | Genentech, Inc. | Phase 3 |
| Completed | A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Centra NCT00485836 | Genentech, Inc. | Phase 3 |
| Terminated | Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO NCT00566761 | Asociación para Evitar la Ceguera en México | Phase 4 |
| Completed | A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involv NCT00473330 | Genentech, Inc. | Phase 3 |
| Completed | A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involv NCT00473382 | Genentech, Inc. | Phase 3 |
| Completed | A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO NCT00567697 | Aleris Helse | Phase 3 |
| Terminated | Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II) NCT00668785 | Jumper, J. Michael, M.D. | Phase 2 |
| Completed | Evaluation of Retinal Structure With High Resolution Optical Coherence Tomography (OCT) NCT00564291 | Sebastian Wolf | — |
| Withdrawn | Pilot Study Reduced Fluence PDT /Visudyne With Ranibizumab vs Ranibizumab Monotherapy for Exudative Age-relate NCT00726973 | Lahey Clinic | N/A |
| Terminated | Combined Vitrectomy and Triamcinolone in Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO) NCT00642226 | Helse Stavanger HF | Phase 3 |
| Completed | Sheathotomy vs. Intravitreal Triamcinolone for Branch Retinal Vein Occlusion NCT00612261 | Yonsei University | N/A |
| Completed | Diabetic Macular Edema Severity at Diagnosis NCT00886392 | Hospital Juarez de Mexico | — |
| Completed | Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT) NCT00729846 | California Retina Consultants | Phase 2 |
| Completed | Combined Triple Therapy in Diabetic Retinopathy (DRP) NCT00806169 | Johann Wolfgang Goethe University Hospital | Phase 3 |
| Completed | Efficacy and Safety Study of Intravitreal Triamcinolone to Treat Diffuse Diabetic Macular Edema NCT00309192 | Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA | Phase 3 |
| Completed | Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis NCT00344253 | Heidelberg University | Phase 3 |
| Completed | Visual Function, Center Point Thickness and Macular Volume After Photocoagulation NCT00906659 | Hospital Juarez de Mexico | — |
| Completed | Ranibizumab (Lucentis) for Macular Edema Secondary to Vein Occlusions NCT00407355 | Peter A Campochiaro, MD | Phase 1 / Phase 2 |
| Completed | Efalizumab to Treat Uveitis NCT00280826 | National Eye Institute (NEI) | Phase 1 |
| Completed | Retinal OCT and (mfERG) Related to Age, Sex, and the Use of Anti-inflammatory Medications NCT00476593 | Norwegian University of Science and Technology | N/A |
| Completed | Steroid Injections vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel Blockage NCT00106132 | National Eye Institute (NEI) | Phase 3 |
| Completed | A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion NCT00168298 | Allergan | Phase 3 |
| Completed | A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion NCT00168324 | Allergan | Phase 3 |
| Completed | 20- Versus 23- Gauge System for Pars Plana Vitrectomy NCT00411970 | The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | Phase 4 |
| Completed | Diffuse Diabetic Maculopathy With Intravitreal Triamcinolone or Laser NCT00668239 | Hospital de Clinicas de Porto Alegre | N/A |
| Completed | Laser and Antioxidant Treatment of Diabetic Macular Edema NCT00055042 | National Eye Institute (NEI) | Phase 1 |
| Completed | Laser and Medical Treatment of Diabetic Macular Edema NCT00027287 | National Eye Institute (NEI) | Phase 1 |
| Completed | Research Study in Patients With Persistent Macular Edema NCT00035906 | Allergan | Phase 2 |
| Completed | Clinical Trial on Alpha Lipoic Acid in Diabetic Macular Edema NCT01208948 | Ludwig-Maximilians - University of Munich | Phase 3 |
| Unknown | Intravitreal Bevacizumab for Diabetic Macular Edema NCT00703235 | Isfahan Ophthalmology Research Center | Phase 2 / Phase 3 |
| Completed | A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occ NCT00308477 | Sanwa Kagaku Kenkyusho Co., Ltd. | Phase 1 / Phase 2 |
| Completed | Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular P NCT00804921 | University of Sao Paulo | Phase 2 |
| Completed | Quality of Life in Patients With Intermediate Uveitis NCT01314469 | St. Franziskus Hospital | — |